Carl Zeiss Meditec (GB:0DHC)

LSE:0DHC

0DHC

Carl Zeiss Meditec

RESEARCH TOOLSreports

Carl Zeiss Meditec (0DHC) Share Forecast & Price Target

18 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0DHC Analyst Ratings

Hold

0 Buy

8 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Carl

Zeiss Meditec

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0DHC Stock 12 Month Forecast

Average Price Target

€27.65

▼(-0.47% Downside)

Based on 9 Wall Street analysts offering 12 month price targets for Carl Zeiss Meditec in the last 3 months. The average price target is €27.65 with a high forecast of €32.00 and a low forecast of €21.70. The average price target represents a -0.47% change from the last price of €27.78.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","29":"€29","38":"€38","47":"€47","56":"€56"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€27.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€21.70</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,29,38,47,56],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.12,26.572307692307692,27.024615384615384,27.47692307692308,27.92923076923077,28.38153846153846,28.833846153846153,29.286153846153848,29.73846153846154,30.19076923076923,30.643076923076922,31.095384615384617,31.54769230769231,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.12,26.23769230769231,26.355384615384615,26.473076923076924,26.59076923076923,26.70846153846154,26.826153846153847,26.943846153846152,27.06153846153846,27.17923076923077,27.296923076923076,27.414615384615384,27.53230769230769,{"y":27.65,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.12,25.78,25.44,25.1,24.76,24.42,24.08,23.740000000000002,23.4,23.06,22.72,22.38,22.04,{"y":21.7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":53.64,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.205,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.65,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.381,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.442,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.029,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.658,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.117,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.186,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.25,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":24.92,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":26.52,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":26.12,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€32.00

Average Price Target€27.65

Lowest Price Target€21.70

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Felton

Goldman Sachs

€31→€28

Hold

0.79%

Upside

Reiterated

05/14/26

Carl Zeiss Meditec (0DHC) Gets a Hold from Goldman Sachs

Oliver Reinberg

Kepler Capital

€28

Hold

0.79%

Upside

Reiterated

05/14/26

Carl Zeiss Meditec (0DHC) Receives a Hold from Kepler Capital

Falko Friedrichs

Deutsche Bank

€30

Hold

7.99%

Upside

Reiterated

05/13/26

Deutsche Bank Sticks to Its Hold Rating for Carl Zeiss Meditec (0DHC)

Jonathon Unwin

Barclays

€30→€28

Hold

0.79%

Upside

Assigned

05/13/26

Barclays Remains a Hold on Carl Zeiss Meditec (0DHC)

David Adlington

J.P. Morgan

€22.4→€21.7

Sell

-21.89%

Downside

Reiterated

05/13/26

Carl Zeiss Meditec (0DHC) Gets a Sell from J.P. Morgan

Graham Doyle

UBS

€25

Hold

-10.01%

Downside

Reiterated

05/12/26

Carl Zeiss Meditec (0DHC) Gets a Hold from UBS

Susannah Ludwig

Bernstein

€28.5

Hold

2.59%

Upside

Reiterated

05/12/26

Bernstein Reaffirms Their Hold Rating on Carl Zeiss Meditec (0DHC)

Charles Weston

RBC Capital

€32

Hold

15.19%

Upside

Reiterated

05/12/26

RBC Capital Keeps Their Hold Rating on Carl Zeiss Meditec (0DHC)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Hold

―

Reiterated

03/25/26

DZ BANK AG Sticks to Their Hold Rating for Carl Zeiss Meditec (0DHC)

Sam England

Berenberg Bank

€35→€30

Hold

7.99%

Upside

Reiterated

02/20/26

Carl Zeiss Meditec (0DHC) Gets a Hold from Berenberg Bank

Alexander Galitsa

Hauck & Aufhaeuser

€70→€68

Buy

144.78%

Upside

Reiterated

08/08/25

Carl Zeiss Meditec (0DHC) Receives a Buy from Hauck & Aufhaeuser

Dylan Van Haaften

Stifel Nicolaus

€60→€50

Hold

79.99%

Upside

Reiterated

08/05/25

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Felton

Goldman Sachs

€31→€28

Hold

0.79%

Upside

Reiterated

05/14/26

Carl Zeiss Meditec (0DHC) Gets a Hold from Goldman Sachs

Oliver Reinberg

Kepler Capital

€28

Hold

0.79%

Upside

Reiterated

05/14/26

Carl Zeiss Meditec (0DHC) Receives a Hold from Kepler Capital

Falko Friedrichs

Deutsche Bank

€30

Hold

7.99%

Upside

Reiterated

05/13/26

Deutsche Bank Sticks to Its Hold Rating for Carl Zeiss Meditec (0DHC)

Jonathon Unwin

Barclays

€30→€28

Hold

0.79%

Upside

Assigned

05/13/26

Barclays Remains a Hold on Carl Zeiss Meditec (0DHC)

David Adlington

J.P. Morgan

€22.4→€21.7

Sell

-21.89%

Downside

Reiterated

05/13/26

Carl Zeiss Meditec (0DHC) Gets a Sell from J.P. Morgan

Graham Doyle

UBS

€25

Hold

-10.01%

Downside

Reiterated

05/12/26

Carl Zeiss Meditec (0DHC) Gets a Hold from UBS

Susannah Ludwig

Bernstein

€28.5

Hold

2.59%

Upside

Reiterated

05/12/26

Bernstein Reaffirms Their Hold Rating on Carl Zeiss Meditec (0DHC)

Charles Weston

RBC Capital

€32

Hold

15.19%

Upside

Reiterated

05/12/26

RBC Capital Keeps Their Hold Rating on Carl Zeiss Meditec (0DHC)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Hold

―

Reiterated

03/25/26

DZ BANK AG Sticks to Their Hold Rating for Carl Zeiss Meditec (0DHC)

Sam England

Berenberg Bank

€35→€30

Hold

7.99%

Upside

Reiterated

02/20/26

Carl Zeiss Meditec (0DHC) Gets a Hold from Berenberg Bank

Alexander Galitsa

Hauck & Aufhaeuser

€70→€68

Buy

144.78%

Upside

Reiterated

08/08/25

Carl Zeiss Meditec (0DHC) Receives a Buy from Hauck & Aufhaeuser

Dylan Van Haaften

Stifel Nicolaus

€60→€50

Hold

79.99%

Upside

Reiterated

08/05/25

Stocks with the Highest Top Analyst Consensus in the General Sector

AVEXAEVEX Corp. Class A

GENBGenerate Biomedicines, Inc.

KLRAKailera Therapeutics, Inc.

HMHHMH Holding Inc. Class A

SGPSpyGlass Pharma

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Carl Zeiss Meditec

3 Months

Alexander GalitsaHauck & Aufhaeuser

Success Rate

15/34 ratings generated profit

Average Return

-2.13%

Copying Alexander Galitsa's trades and holding each position for 3 Months would result in 44.12% of your transactions generating a profit, with an average return of -2.13% per trade.

1 Year

Alexander GalitsaHauck & Aufhaeuser

Success Rate

5/34 ratings generated profit

Average Return

-23.04%

Copying Alexander Galitsa's trades and holding each position for 1 Year would result in 14.71% of your transactions generating a profit, with an average return of -23.04% per trade.

2 Years

Alexander GalitsaHauck & Aufhaeuser

Success Rate

4/34 ratings generated profit

Average Return

-41.60%

Copying Alexander Galitsa's trades and holding each position for 2 Years would result in 11.76% of your transactions generating a profit, with an average return of -41.60% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0DHC Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0DHC has received 0 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. 0DHC average Analyst price target in the past 3 months is 27.65.

Each month's total comprises the sum of three months' worth of ratings.

0DHC Financial Forecast

0DHC Earnings Forecast

Next quarter’s earnings estimate for 0DHC is €0.43 with a range of €0.42 to €0.44. The previous quarter’s EPS was €0.45. 0DHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 0DHC has Performed in-line its overall industry.

0DHC Sales Forecast

Next quarter’s sales forecast for 0DHC is €547.28M with a range of €534.15M to €560.40M. The previous quarter’s sales results were €990.98M. 0DHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 0DHC has Performed in-line its overall industry.

0DHC Stock Forecast FAQ

What is GB:0DHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Carl Zeiss Meditec’s 12-month average price target is 27.65.

What is GB:0DHC’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GB:0DHC, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Carl Zeiss Meditec a Buy, Sell or Hold?

Carl Zeiss Meditec has a consensus rating of Hold, which is based on 0 buy ratings, 8 hold ratings and 1 sell ratings.

What is Carl Zeiss Meditec’s share price target?

The average share price target for Carl Zeiss Meditec is 27.65. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €32.00 ,and the lowest forecast is €21.70. The average share price target represents -0.47% Decrease from the current price of €27.78.

What do analysts say about Carl Zeiss Meditec?

Carl Zeiss Meditec’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Carl Zeiss Meditec?

To buy shares of GB:0DHC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Carl Zeiss Meditec (0DHC) Share Forecast & Price Target

0DHC Analyst Ratings

0DHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Carl Zeiss Meditec

0DHC Analyst Recommendation Trends

0DHC Financial Forecast

0DHC Earnings Forecast

0DHC Sales Forecast

0DHC Stock Forecast FAQ

Detailed List of Analyst Forecasts